1.1 Repetition of SH by post‐intervention (NGA class) |
2 |
129 |
Odds Ratio (M‐H, Random, 95% CI) |
0.59 [0.29, 1.19] |
1.1.1 Mianserin vs. Placebo |
1 |
38 |
Odds Ratio (M‐H, Random, 95% CI) |
0.67 [0.18, 2.41] |
1.1.2 Paroxetine vs. Placebo |
1 |
91 |
Odds Ratio (M‐H, Random, 95% CI) |
0.55 [0.24, 1.29] |
1.2 Repetition of SH at final follow‐up (by NGA class) |
3 |
243 |
Odds Ratio (M‐H, Random, 95% CI) |
0.75 [0.42, 1.35] |
1.2.1 Mianserin vs. Placebo |
2 |
95 |
Odds Ratio (M‐H, Random, 95% CI) |
1.07 [0.39, 2.99] |
1.2.2 Nomifensine vs. Placebo |
1 |
57 |
Odds Ratio (M‐H, Random, 95% CI) |
0.81 [0.17, 3.81] |
1.2.3 Paroxetine vs. Placebo |
1 |
91 |
Odds Ratio (M‐H, Random, 95% CI) |
0.55 [0.24, 1.29] |
1.3 Treatment acceptability |
2 |
205 |
Odds Ratio (M‐H, Random, 95% CI) |
0.70 [0.29, 1.71] |